What is Commons Clinic?
Commons Clinic operates as a pioneering, specialty-led healthcare platform designed to unify fragmented medical services into a single, accountable system. The company's market position is defined by its ability to integrate advanced diagnostics with personalized care pathways across diverse clinical domains, including musculoskeletal health, cardiovascular wellness, metabolic management, and preventive oncology. By centralizing these critical functions, the clinic aims to improve patient outcomes through seamless, data-driven interventions that prioritize both efficiency and clinical excellence. This integrated approach represents a shift away from traditional, siloed healthcare delivery models toward a more cohesive, patient-centric ecosystem.
How much funding has Commons Clinic raised?
Commons Clinic has raised a total of $66.6M across 4 funding rounds:
Angel/Seed
$11M
Series A
$19.5M
Series B
$26M
Stock/Share Issuance
$10.1M
Angel/Seed (2022): $11M with participation from Vast Ventures and Oxeon
Series A (2023): $19.5M led by Courtside Ventures, RA Capital Management, and Floating Point Group
Series B (2025): $26M supported by SteelSky Ventures, Floating Point, RA Capital Management, Courtside Ventures, and Time BioVentures
Stock/Share Issuance (2026): $10.1M, investors not publicly disclosed
Key Investors in Commons Clinic
RA Capital Management
A multi-stage investment manager focused on evidence-based investing in healthcare and life science companies, utilizing their TechAtlas think tank to analyze clinical data.
Courtside Ventures
An early-stage venture capital firm that partners with entrepreneurs redefining wellness and lifestyle sectors, with a strong focus on global trends and personalized health.
Time BioVentures
A full-spectrum venture capital firm based in Southern California that finances transformative healthcare technologies aimed at enhancing patient quality of life.
What's next for Commons Clinic?
Looking ahead, the recent capital infusion will likely be deployed to scale the company's proprietary care delivery infrastructure and expand its reach into new clinical specialties. As Commons Clinic transitions into a more mature phase of its lifecycle, the focus will shift toward optimizing its interventional procedures and deepening its integration with existing healthcare networks. The strategic backing from a diverse group of life science and healthcare-focused investors provides the necessary resources to navigate the complexities of the current medical landscape. Future growth will be predicated on the firm's ability to maintain its high standard of personalized care while achieving the operational scale required to disrupt traditional healthcare delivery systems on a broader, more systemic level.
See full Commons Clinic company page
